American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$310M |
| 2 |
AbbVie
ABBV
|
+$279M |
| 3 |
L3Harris
LHX
|
+$251M |
| 4 |
VeriSign
VRSN
|
+$238M |
| 5 |
Jacobs Solutions
J
|
+$226M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$510M |
| 2 |
Texas Instruments
TXN
|
+$504M |
| 3 |
Adobe
ADBE
|
+$416M |
| 4 |
PayPal
PYPL
|
+$378M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$295M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.49% |
| 2 | Financials | 14.96% |
| 3 | Healthcare | 14.78% |
| 4 | Consumer Discretionary | 11.09% |
| 5 | Industrials | 9.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WOW
1051
DELISTED
WideOpenWest
WOW
| $6.29M | 0.01% |
345,319
+254,724
| +281% | +$5.12M |
|
1052
Constellium
CSTM
$3.95B
| $6.28M | 0.01% |
475,478
-273,740
| -37% | -$4.38M |
|
1053
Patterson-UTI
PTEN
$4.16B
| $6.19M | 0.01% |
392,479
+61,399
| +19% | +$1.03M |
|
1054
Apogee Enterprises
APOG
$888M
| $6.17M | 0.01% |
157,236
+26,229
| +20% | +$1.12M |
|
|
DVAX
1055
DELISTED
Dynavax Technologies
DVAX
| $6.15M | 0.01% |
488,706
+401,814
| +462% | +$4.27M |
|
1056
Autodesk
ADSK
$54.5B
| $6.14M | 0.01% |
35,695
-11,330
| -24% | -$2.18M |
|
1057
Buckle
BKE
$2.31B
| $6.13M | 0.01% |
221,485
+48,658
| +28% | +$1.53M |
|
1058
Harmony Gold Mining
HMY
$12B
| $6.1M | 0.01% |
1,947,692
-1,446
| -0.1% | -$5.56K |
|
1059
O'Reilly Automotive
ORLY
$74.9B
| $6.07M | 0.01% |
144,030
-129,390
| -47% | -$5.57M |
|
1060
ON Semiconductor
ON
$31.8B
| $6.07M | 0.01% |
120,541
+490
| +0.4% | +$27.3K |
|
1061
Ross Stores
ROST
$78.6B
| $6.04M | ﹤0.01% |
85,991
+30,143
| +54% | +$2.68M |
|
1062
Graham Corp
GHM
$1.3B
| $6.03M | ﹤0.01% |
871,858
+2,280
| +0.3% | +$17.3K |
|
1063
Baidu
BIDU
$35.5B
| $6.01M | ﹤0.01% |
40,425
+3,198
| +9% | +$423K |
|
1064
Genco Shipping & Trading
GNK
$1.13B
| $6.01M | ﹤0.01% |
310,928
+138,060
| +80% | +$3.11M |
|
1065
Teradyne
TER
$64.2B
| $5.98M | ﹤0.01% |
66,739
+17,091
| +34% | +$1.78M |
|
1066
G-III Apparel Group
GIII
$1.43B
| $5.95M | ﹤0.01% |
294,184
+68,389
| +30% | +$1.73M |
|
1067
Casey's General Stores
CASY
$31.6B
| $5.93M | ﹤0.01% |
32,079
+19,596
| +157% | +$3.94M |
|
1068
Regenxbio
RGNX
$704M
| $5.92M | ﹤0.01% |
239,665
+191,668
| +399% | +$4.79M |
|
|
SAGE
1069
DELISTED
Sage Therapeutics
SAGE
| $5.89M | ﹤0.01% |
182,426
-109,660
| -38% | -$3.68M |
|
1070
BlueLinx
BXC
$705M
| $5.89M | ﹤0.01% |
88,122
+22,995
| +35% | +$1.73M |
|
1071
3M
MMM
$94.2B
| $5.88M | ﹤0.01% |
54,377
+6,390
| +13% | +$772K |
|
|
ARGO
1072
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $5.88M | ﹤0.01% |
159,493
+79,424
| +99% | +$3.26M |
|
1073
NBT Bancorp
NBTB
$2.79B
| $5.83M | ﹤0.01% |
155,234
+64,014
| +70% | +$2.32M |
|
1074
Fate Therapeutics
FATE
$294M
| $5.83M | ﹤0.01% |
235,235
+18,560
| +9% | +$512K |
|
1075
Designer Brands
DBI
$312M
| $5.8M | ﹤0.01% |
443,937
+376,065
| +554% | +$5.42M |
|
Similar funds
American Century Companies's Q2 2022 Portfolio in Review
As of Q2 2022, American Century Companies held 2,437 positions worth $122B, down 16% from $146B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
American Century Companies's Q2 2022 filing shows 146 new, 1,442 increased, 596 reduced and 133 closed positions. Its largest new stake was Maravai LifeSciences: 2,396,740 shares worth $68.1M. The largest sale was Meta Platforms (Facebook), an estimated $510M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.
- American Century Companies's largest Q2 2022 buy was Maravai LifeSciences: 2,396,740 shares worth $68.1M.
- American Century Companies added most to NVIDIA in Q2 2022, an estimated $310M increase.
- American Century Companies's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $510M.
- American Century Companies fully exited iShares Russell Mid-Cap Value ETF in Q2 2022, selling an estimated $278M.
- American Century Companies's ten largest holdings make up 21% of its $122B portfolio in Q2 2022.
- American Century Companies opened 146 new positions and closed 133 in Q2 2022.
- American Century Companies's portfolio value fell 16% quarter-over-quarter to $122B.
Based on American Century Companies's 13F filing for Q2 2022, filed 12 Aug 2022.